GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genus GNS.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

2,410.00p

+0.75%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2026

Revenue

£658.1m

FY2017FY2026

Net income

£285.3m

FY2017FY2026

Free cash flow

£78.0m

FY2017FY2026

Shareholders' equity

£766.7m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue£658.1m£672.8m£668.8m£689.7m£593.4m£574.3m£551.4m£488.5m£470.3m£459.1m
Research and development—£15.6m£37.3m£93.3m£72.9m£68.1m£71.4m£60.9m£51.4m£45.4m
Operating income£87.3m£42.4m£6.4m£40.5m£56.6m£61.5m£31.1m£39.2m£12.8m£37.7m
Net income£285.3m£19.3m£7.9m£33.3m£40.9m£47.3m£35.3m£7.8m£42.7m£32.8m
Diluted earnings per share4.250.290.120.500.620.720.540.120.690.53

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets£1.02bn£899.0m£1.03bn£1.01bn£1.02bn£851.0m£855.4m£803.6m£789.2m£797.6m
Cash and short-term investments£43.7m£48.0m£42.5m£36.3m£38.8m£46.0m£41.3m£30.5m£31.6m£26.5m
Total liabilities£251.6m£423.0m£485.0m£440.3m£445.8m£354.4m£360.9m£316.5m£370.1m£395.5m
Debt£107.5m£265.9m£291.2m£232.1m£223.8m£151.6m£143.9m£110.1m£137.6m£138.1m
Shareholders' equity£766.7m£475.6m£548.2m£569.4m£578.5m£498.1m£495.5m£488.4m£416.6m£399.3m
Shares outstanding67m67m66m66m66m66m66m65m62m62m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations£90.5m£67.2m£29.8m£50.4m£34.3m£67.5m£65.8m£33.4m£43.2m£34.6m
Capital spending−£12.5m−£18.6m−£24.7m−£35.2m−£50.9m−£33.8m−£35.4m−£17.1m−£17.8m−£13.4m
Free cash flow£78.0m£48.6m£5.1m£15.2m−£16.6m£33.7m£30.4m£16.3m£25.4m£21.2m
Dividends paid−£21.7m−£21.1m−£21.0m−£21.0m−£20.9m−£19.5m−£18.3m−£16.8m−£14.9m−£13.5m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
Revenue£322.5m£335.6m£336.4m£336.4m£335.2m£333.6m£339.5m£350.2m
Operating income£51.5m£35.8m£29.9m£12.5m−£14.9m£21.3m£25.8m£14.7m
Net income£255.5m£29.8m£17.7m£1.6m−£5.6m£13.5m£19.9m£13.4m
Diluted earnings per share3.810.440.260.02-0.080.200.300.20
Cash from operations£67.0m£22.0m£47.0m£25.0m£24.0m£10.0m£41.0m£8.0m
Capital spending−£7.0m−£5.0m−£8.0m−£5.0m−£5.0m−£14.0m−£20.0m−£12.0m
Free cash flow£60.0m£17.0m£39.0m£20.0m£19.0m−£4.0m£21.0m−£4.0m
Total assets£1.02bn£921.3m£899.0m£985.9m£1.03bn£1.05bn£1.01bn£1.02bn
Cash and short-term investments£43.7m£43.4m£48.0m£47.4m£42.5m£42.0m£36.3m£42.3m
Debt£14.1m£243.7m£232.1m£274.4m£247.1m£244.7m£210.2m£232.1m
Shareholders' equity£766.7m£504.0m£475.6m£516.6m£548.2m£569.3m£569.4m£572.4m

Financial ratios

Data as of 30 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Operating margin13.3%7.3%4.0%6.4%9.5%10.5%
Net margin43.4%2.9%1.2%4.8%6.9%8.2%
Return on equity37.2%4.1%1.4%5.8%7.1%9.5%
Return on assets28.0%2.1%0.8%3.3%4.0%5.6%
Free cash flow yield0.1%0.1%0.0%0.1%0.1%0.1%
Revenue growth-2.2%0.6%-3.0%16.2%3.3%4.2%
Earnings growth1378.2%144.3%-76.3%-18.6%-13.5%34.0%
Current ratio2.22x1.94x1.80x1.76x1.70x1.63x
Debt to equity0.12x0.49x0.45x0.37x0.36x0.27x
Equity ratio75.3%52.9%53.3%56.5%56.8%58.5%
Interest coverage5.36x2.39x1.24x2.94x9.13x13.40x
R&D as a share of sales2.9%2.3%5.6%13.5%12.3%11.9%
Buybacks as a share of market value-0.2%-0.8%-0.4%-0.4%-0.2%-0.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.6%2.8%5.4%
Operating income29.2%7.3%8.9%
Net income104.6%43.2%19.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin9.7%6.6%7.6%7.3%
Net margin22.9%12.9%11.3%9.7%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings5.690.6130.243.248.368.678.2266.631.047.7
Price to sales2.42.61.52.13.35.75.04.32.83.4

Dividends and splits

Per share, in the currency the company pays

Paid for 25 years. Last went ex-dividend on 5 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.3290.320.320.320.320.300.2820.268

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.